Navigation Links
ORNL, Southern Cal set sights on preventing blindness

Blindness in millions of people with diseases that starve eye tissue and nerves of oxygen might be averted with a procedure being developed by researchers at Oak Ridge National Laboratory, the University of Southern California and the University of Tennessee.

The technique uses a new class of smart prosthetic implants to provide oxygen to retinal tissue being deprived of oxygen because of restricted blood flow. This condition occurs predominantly in patients with diabetic retinopathy (, which affects an estimated 5.5 million people each year.

Elias Greenbaum of the Department of Energy's ORNL noted that this research builds upon the highly successful artificial retina project ( officially kicked off in 2004. For this project, Greenbaum and colleagues at ORNL are joined by Mark Humayun of the Doheny Eye Institute and Keck School of Medicine at the University of Southern California and Dan Close of the University of Tennessee.

"We have assembled a team of researchers with precisely the right capabilities to tackle this problem of immense proportions," said Greenbaum, lead author of a paper published in IEEE Transactions on Biomedical Engineering. Animal studies for the metabolic prosthesis technique are under way.

The procedure involves surgically implanting a feedback-controlled three-electrode electrolysis system that stimulates production of oxygen near the retina. The electrodes provide small amounts of current in very short pulses about 200 microseconds. This results in a rapid production of oxygen and suppressed production of chlorine, which is potentially harmful.

"What we've been able to do is find a way to provide oxygen to the retina while avoiding the formation of potentially harmful chlorine," Greenbaum said.

By using three electrodes and a feedback loop made possible by implanting a "ground" electrode behind the patient's ear, the research team is able to maintain constant pH in the area being treated. At the same time, any pH drift can be exported to a surface-accessible region where it can be easily dealt with, according to the researchers.

Others involved in this project are Charlene Sanders, Hugh O'Neill and Barbara Evans, who, like Greenbaum, are members of ORNL's Chemical Sciences Division.


Contact: Ron Walli
DOE/Oak Ridge National Laboratory

Related biology news :

1. New southernpeas developed by ARS, cooperators
2. MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
3. Climate change and life in the Southern Ocean
4. Southern California institutions to collaborate on stem cell research
5. Antarctic expedition provides new insights into the role of the Southern Ocean for global climate
6. Voyage to Southern Ocean aims to study air-sea fluxes of greenhouse gases
7. Soybean varieties viable in southern Indiana, resistant to root-knot nematode
8. Ozone hole recovery may reshape southern hemisphere climate change
9. UC Riverside to host conference on stricter air quality standards for Southern California
10. Unmanned aircraft to study Southern California smog and its consequences
11. Southern Ocean seals dive deep for climate data
Post Your Comments:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology: